We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Mylan has launched a generic version of Janssen’s Invega, following FDA approval of its ANDA for the atypical antipsychotic drug, the company announced Sept. 28.